Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors

PURPOSE: To evaluate the incidence, diagnosis and treatment of immune-related adverse events (e-irAE) of checkpoint inhibition (ICI) in metastatic urothelial carcinoma (mUC) and metastatic renal cell carcinoma (mRCC). METHODS: A retrospective, single-center study was conducted to identify a cohort t...

Descripción completa

Detalles Bibliográficos
Autores principales: Oppolzer, Immanuel Augustin, Riester, Josef, Büttner, Roland, Burger, Maximilian, Schnabel, Marco Julius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Urology - Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329606/
https://www.ncbi.nlm.nih.gov/pubmed/37271776
http://dx.doi.org/10.1007/s11255-023-03635-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329606/
https://www.ncbi.nlm.nih.gov/pubmed/37271776
http://dx.doi.org/10.1007/s11255-023-03635-9

Ejemplares similares